Return On Equity of NRX Pharmaceuticals, Inc. from 30 Sep 2018 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
NRX Pharmaceuticals, Inc. quarterly and annual Return On Equity in % history and change rate from 30 Sep 2018 to 30 Sep 2025.
  • NRX Pharmaceuticals, Inc. Return On Equity for the quarter ending 30 Sep 2025 was 139%, a 14% decline year-over-year.
  • NRX Pharmaceuticals, Inc. annual Return On Equity for 2024 was 133%, a 77% decline from 2023.
  • NRX Pharmaceuticals, Inc. annual Return On Equity for 2023 was 573%.
  • NRX Pharmaceuticals, Inc. annual Return On Equity for 2022 was -196%, a 102% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

NRX Pharmaceuticals, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 139% -23% -14% 01 Jul 2025 30 Sep 2025
Q2 2025 131% -105% -44% 01 Apr 2025 30 Jun 2025
Q1 2025 113% -235% -68% 01 Jan 2025 31 Mar 2025
Q4 2024 133% -440% -77% 01 Oct 2024 31 Dec 2024
Q3 2024 162% -6266% -97% 01 Jul 2024 30 Sep 2024
Q2 2024 236% +872% 01 Apr 2024 30 Jun 2024
Q1 2024 348% +606% 01 Jan 2024 31 Mar 2024
Q4 2023 573% +769% 01 Oct 2023 31 Dec 2023
Q3 2023 6428% +6681% 01 Jul 2023 30 Sep 2023
Q2 2023 -636% -229% -56% 01 Apr 2023 30 Jun 2023
Q1 2023 -258% +1270% +83% 01 Jan 2023 31 Mar 2023
Q4 2022 -196% -9302% -102% 01 Oct 2022 31 Dec 2022
Q3 2022 -253% -881% -140% 01 Jul 2022 30 Sep 2022
Q2 2022 -407% -787% -207% 01 Apr 2022 30 Jun 2022
Q1 2022 -1528% -2184% -333% 01 Jan 2022 31 Mar 2022
Q4 2021 9106% +8753% +2478% 01 Oct 2021 31 Dec 2021
Q3 2021 628% +493% +364% 01 Jul 2021 30 Sep 2021
Q2 2021 380% +331% +681% 01 Apr 2021 30 Jun 2021
Q1 2021 656% +86% +15% 01 Jan 2021 31 Mar 2021
Q4 2020 353% +337% +2096% 01 Oct 2020 31 Dec 2020
Q3 2020 135% -6% -4.1% 01 Jul 2020 30 Sep 2020
Q2 2020 49% -92% -65% 01 Apr 2020 30 Jun 2020
Q1 2020 570% +565% +11847% 01 Jan 2020 31 Mar 2020
Q4 2019 16% +15% +1116% 01 Oct 2019 31 Dec 2019
Q3 2019 141% +274% 01 Jul 2019 30 Sep 2019
Q2 2019 140% 01 Apr 2019 30 Jun 2019
Q1 2019 5% 01 Jan 2019 31 Mar 2019
Q4 2018 1% 01 Oct 2018 31 Dec 2018
Q3 2018 -133% 01 Jul 2018 30 Sep 2018

NRX Pharmaceuticals, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 133% -440% -77% 01 Jan 2024 31 Dec 2024
2023 573% +769% 01 Jan 2023 31 Dec 2023
2022 -196% -9302% -102% 01 Jan 2022 31 Dec 2022
2021 9106% +8753% +2478% 01 Jan 2021 31 Dec 2021
2020 353% +337% +2096% 01 Jan 2020 31 Dec 2020
2019 16% +15% +1116% 01 Jan 2019 31 Dec 2019
2018 1% 01 Jan 2018 31 Dec 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.